Kobayashi Pharmaceutical Co Ltd
TSE:4967
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Price:
5 632
JPY
-0.09%
Market Closed
Market Cap:
¥418.7B
Balance Sheet
Balance Sheet Decomposition
Kobayashi Pharmaceutical Co Ltd
Kobayashi Pharmaceutical Co Ltd
Balance Sheet Decomposition is not available for
Kobayashi Pharmaceutical Co Ltd
Kobayashi Pharmaceutical Co Ltd
Balance Sheet
Kobayashi Pharmaceutical Co Ltd
Kobayashi Pharmaceutical Co Ltd
Currency: JPY
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
58 173
|
64 990
|
74 456
|
75 580
|
78 253
|
95 024
|
96 233
|
71 536
|
50 873
|
62 314
|
|
| Cash Equivalents |
58 173
|
64 990
|
74 456
|
75 580
|
78 253
|
95 024
|
96 233
|
71 536
|
50 873
|
62 314
|
|
| Short-Term Investments |
5 500
|
8 300
|
8 300
|
14 977
|
16 085
|
14 022
|
8 300
|
8 300
|
14 872
|
8 300
|
|
| Total Receivables |
47 000
|
49 998
|
53 255
|
54 105
|
52 829
|
55 147
|
47 853
|
52 984
|
49 384
|
52 135
|
|
| Accounts Receivables |
47 000
|
49 998
|
53 255
|
54 105
|
52 829
|
55 147
|
47 853
|
52 984
|
49 384
|
52 135
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
12 805
|
13 289
|
13 643
|
15 325
|
14 139
|
15 107
|
17 678
|
22 081
|
24 163
|
22 752
|
|
| Other Current Assets |
5 168
|
5 769
|
2 170
|
3 059
|
2 919
|
2 589
|
2 828
|
3 430
|
5 176
|
3 319
|
|
| Total Current Assets |
128 646
|
142 346
|
151 824
|
163 046
|
164 225
|
181 889
|
172 892
|
158 331
|
144 468
|
148 820
|
|
| PP&E Net |
17 833
|
18 247
|
19 024
|
21 180
|
20 821
|
22 524
|
34 778
|
47 665
|
67 448
|
67 367
|
|
| Intangible Assets |
2 494
|
2 172
|
1 582
|
1 530
|
5 510
|
5 469
|
6 160
|
11 959
|
11 414
|
9 703
|
|
| Goodwill |
4 729
|
2 626
|
3 241
|
1 582
|
7 284
|
7 189
|
7 147
|
9 655
|
9 260
|
7 711
|
|
| Note Receivable |
171
|
261
|
386
|
572
|
700
|
816
|
975
|
1 132
|
1 269
|
1 334
|
|
| Long-Term Investments |
43 248
|
49 778
|
48 872
|
42 260
|
37 239
|
32 201
|
31 216
|
34 802
|
27 267
|
34 282
|
|
| Other Long-Term Assets |
4 113
|
3 401
|
3 858
|
3 562
|
2 587
|
2 466
|
2 659
|
3 929
|
4 242
|
6 112
|
|
| Other Assets |
4 729
|
2 626
|
3 241
|
1 582
|
7 284
|
7 189
|
7 147
|
9 655
|
9 260
|
7 711
|
|
| Total Assets |
201 234
N/A
|
218 831
+9%
|
228 787
+5%
|
233 732
+2%
|
238 366
+2%
|
252 554
+6%
|
255 827
+1%
|
267 473
+5%
|
265 368
-1%
|
275 329
+4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
16 018
|
17 500
|
17 776
|
16 815
|
15 926
|
17 444
|
18 056
|
17 305
|
14 688
|
14 898
|
|
| Accrued Liabilities |
2 237
|
3 495
|
3 542
|
3 592
|
4 214
|
3 125
|
3 474
|
3 493
|
3 186
|
4 190
|
|
| Short-Term Debt |
192
|
194
|
506
|
19
|
13
|
1
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
56
|
55
|
53
|
190
|
170
|
169
|
261
|
379
|
343
|
319
|
|
| Other Current Liabilities |
28 472
|
33 030
|
33 176
|
33 151
|
29 784
|
29 964
|
30 018
|
34 934
|
28 206
|
40 730
|
|
| Total Current Liabilities |
46 975
|
54 274
|
55 053
|
53 767
|
50 107
|
50 703
|
51 809
|
56 111
|
46 423
|
60 137
|
|
| Long-Term Debt |
581
|
527
|
472
|
682
|
505
|
460
|
531
|
608
|
503
|
359
|
|
| Deferred Income Tax |
3 841
|
5 224
|
2 812
|
2 779
|
1 357
|
1 564
|
1 310
|
2 594
|
1 554
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
9
|
|
| Other Liabilities |
6 517
|
4 995
|
4 201
|
3 847
|
3 814
|
4 227
|
4 277
|
3 344
|
3 417
|
3 825
|
|
| Total Liabilities |
57 914
N/A
|
65 020
+12%
|
62 538
-4%
|
61 075
-2%
|
55 783
-9%
|
56 954
+2%
|
57 927
+2%
|
62 657
+8%
|
51 901
-17%
|
64 330
+24%
|
|
| Equity | |||||||||||
| Common Stock |
3 450
|
3 450
|
3 450
|
3 450
|
3 450
|
3 450
|
3 450
|
3 450
|
3 450
|
3 450
|
|
| Retained Earnings |
147 968
|
146 794
|
159 857
|
173 650
|
187 071
|
200 587
|
194 545
|
206 127
|
208 928
|
205 033
|
|
| Additional Paid In Capital |
4 958
|
4 183
|
4 183
|
4 183
|
4 183
|
4 183
|
522
|
522
|
522
|
522
|
|
| Unrealized Security Profit/Loss |
9 481
|
13 267
|
12 636
|
13 212
|
10 449
|
10 953
|
10 346
|
12 819
|
12 469
|
13 085
|
|
| Treasury Stock |
21 088
|
12 259
|
11 763
|
19 762
|
19 763
|
23 706
|
14 482
|
24 766
|
24 767
|
24 767
|
|
| Other Equity |
1 449
|
1 624
|
2 114
|
2 076
|
2 807
|
133
|
3 519
|
6 664
|
12 865
|
13 676
|
|
| Total Equity |
143 320
N/A
|
153 811
+7%
|
166 249
+8%
|
172 657
+4%
|
182 583
+6%
|
195 600
+7%
|
197 900
+1%
|
204 816
+3%
|
213 467
+4%
|
210 999
-1%
|
|
| Total Liabilities & Equity |
201 234
N/A
|
218 831
+9%
|
228 787
+5%
|
233 732
+2%
|
238 366
+2%
|
252 554
+6%
|
255 827
+1%
|
267 473
+5%
|
265 368
-1%
|
275 329
+4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
79
|
82
|
79
|
78
|
78
|
78
|
76
|
74
|
74
|
74
|
|
Switch to:
Switch to:
See Also
Discover More
